Literature DB >> 9581736

Partitioning of pulmonary vascular resistance in primary pulmonary hypertension.

S A Kafi1, C Mélot, J L Vachiéry, S Brimioulle, R Naeije.   

Abstract

OBJECTIVES: This study sought to determine the site of increased pulmonary vascular resistance (PVR) in primary pulmonary hypertension by standard bedside hemodynamic evaluation.
BACKGROUND: The measurement of pulmonary vascular pressures at several levels of flow (Q) allows the discrimination between active and passive, flow-dependent changes in mean pulmonary artery pressure (Ppa), and may detect the presence of an increased pulmonary vascular closing pressure. The determination of a capillary pressure (Pc') from the analysis of a Ppa decay curve after balloon occlusion allows the partitioning of PVR in an arterial and a (capillary + venous) segment. These approaches have not been reported in primary pulmonary hypertension.
METHODS: Ppa and Pc' were measured at baseline and after an increase in Q induced either by exercise or by an infusion of dobutamine, at a dosage up to 8 microg/kg body weight per min, in 11 patients with primary pulmonary hypertension. Reversibility of pulmonary hypertension was assessed by the inhalation of 20 ppm nitric oxide (NO), and, in 6 patients, by an infusion of prostacyclin.
RESULTS: At baseline, Ppa was 52+/-3 mm Hg (mean value+/-SE), Q 2.2+/-0.2 liters/min per m2, and Pc' 29+/-3 mm Hg. Dobutamine did not affect Pc' and allowed the calculation of an averaged extrapolated pressure intercept of Ppa/Q plots of 34 mm Hg. Inhaled NO had no effect. Prostacyclin decreased Pc' and PVR. Exercise increased Pc' to 40+/-3 mm Hg but did not affect PVR.
CONCLUSIONS: ns. These findings are compatible with a major increase of resistance and reactivity at the periphery of the pulmonary arterial tree.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9581736     DOI: 10.1016/s0735-1097(98)00091-6

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  13 in total

1.  Pulmonary vascular resistance. A meaningless variable?

Authors:  Robert Naeije
Journal:  Intensive Care Med       Date:  2003-04       Impact factor: 17.440

Review 2.  Pulmonary hypertension with left-sided heart disease.

Authors:  Marco Guazzi; Ross Arena
Journal:  Nat Rev Cardiol       Date:  2010-10-05       Impact factor: 32.419

Review 3.  Exercise-induced pulmonary hypertension: physiological basis and methodological concerns.

Authors:  Robert Naeije; Rebecca Vanderpool; Bishnu P Dhakal; Rajeev Saggar; Rajan Saggar; Jean-Luc Vachiery; Gregory D Lewis
Journal:  Am J Respir Crit Care Med       Date:  2013-01-24       Impact factor: 21.405

Review 4.  Pulmonary hypertension in patients with heart failure and preserved ejection fraction: differential diagnosis and management.

Authors:  Nehal Hussain; Athanasios Charalampopoulos; Sheila Ramjug; Robin Condliffe; Charlie A Elliot; Laurence O'Toole; Andrew Swift; David G Kiely
Journal:  Pulm Circ       Date:  2016-03       Impact factor: 3.017

Review 5.  Right ventricle in acute and chronic pulmonary embolism (2013 Grover Conference series).

Authors:  Christian Gerges; Nika Skoro-Sajer; Irene M Lang
Journal:  Pulm Circ       Date:  2014-09       Impact factor: 3.017

6.  Pulmonary vascular remodeling before and after pulmonary endarterectomy in patients with chronic thromboembolic pulmonary hypertension: a cardiac magnetic resonance study.

Authors:  Andreas Rolf; Johannes Rixe; Won K Kim; Stefan Guth; Nils Körlings; Helge Möllmann; Holger M Nef; Christoph Liebetrau; Gabriele Krombach; Thorsten Kramm; Eckhard Mayer; Christian W Hamm
Journal:  Int J Cardiovasc Imaging       Date:  2014-12-18       Impact factor: 2.357

7.  Exercise-induced pulmonary arterial hypertension.

Authors:  James J Tolle; Aaron B Waxman; Teresa L Van Horn; Paul P Pappagianopoulos; David M Systrom
Journal:  Circulation       Date:  2008-11-03       Impact factor: 29.690

8.  Endotoxemic pulmonary hypertension is largely mediated by endothelin-induced venous constriction.

Authors:  Patrik Rossi; Björn Persson; Piet J M Boels; Anders Arner; Eddie Weitzberg; Anders Oldner
Journal:  Intensive Care Med       Date:  2008-01-24       Impact factor: 17.440

Review 9.  Pulmonary circulation at exercise.

Authors:  Robert Naeije; N Chesler
Journal:  Compr Physiol       Date:  2012-01       Impact factor: 9.090

10.  Pulmonary vascular dysfunction secondary to pulmonary arterial hypertension: insights gained through retrograde perfusion.

Authors:  Chun Zhou; Edward S Crockett; Lynn Batten; Ivan F McMurtry; Troy Stevens
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-01-18       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.